NRCSMALL

National Research Corporation

HealthcareMedical - Healthcare Information Services
$21.64
$0.01(+3.99%)
52W$11.01
$22.79
Updated Jun 30, 02:00 AM
RSI61
RS Rating87/99
Beta0.49
Volatility57%
F-Score5/9
Mkt Cap$488M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

National Research Corporation is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 87), indicating clear outperformance against the broad market. Earnings contraction of 44% provides fundamental context to the price action. Investors should exercise caution due to high volatility (57% annualized), which requires wider risk management.

Relative Strength
87
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.49
vs S&P 500
LOW VOL
52W Position
90%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$18.81
50 SMA > 100 SMA$17.18
100 SMA > 150 SMA$17.73
150 SMA > 200 SMA$16.70

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$19.60+10.41%ABOVE
50 SMA$18.81+15.06%ABOVE
100 SMA$17.18+25.97%ABOVE
150 SMA$17.73+22.03%ABOVE
200 SMA$16.70+29.57%ABOVE

Price Performance

1D+4.0%
1W+11.0%
1M+10.8%
3M+26.3%
6M+14.1%
YTD+20.0%
1Y+28.8%
3Y-20.9%
52-Week Trading Range90% from low
$21.64
52W Low$11.01
52W High$22.79

Technical Indicators

RSI (14)BULLISH
60.5
305070
Setup ScoreWARM
6/10
Base depth: 32.3%

Risk Profile

Beta
0.49
52W Vol
57%
ATR
$1.17
Max DD (1Y)
-46%

Volume Analysis

Today
77.7K
50D Avg
125.8K
Vol Ratio
0.62x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-102%
$-0.00
Q3'25-25%
$0.18
Q4'25-71%
$0.08
Q1'26-44%
$0.14
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+2.99%
5 Years:+0.61%
3 Years:-3.22%
TTM:-1.88%

Compounded Profit Growth

10 Years:+2.41%
5 Years:-18.54%
3 Years:-25.74%
TTM:-61.39%

Stock Price CAGR

10 Years:+4.75%
5 Years:-14.12%
3 Years:-20.92%
1 Year:+28.81%

Return on Equity

10Y Avg:56.4%
5Y Avg:50.9%
3Y Avg:54.7%
Last Year:57.2%

Key Metrics

Market Cap$488M
Gross Margin56.3%
Net Margin8.4%
Piotroski F-Score5/9

Frequently Asked Questions

Is NRC in an uptrend right now?

NRC has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is NRC overbought or oversold?

NRC's RSI (14) is 61. The stock is in neutral territory, neither overbought nor oversold.

Is NRC outperforming the market?

NRC has a Relative Strength (RS) Rating of 87 out of 99. Yes, NRC is a market leader, outperforming 87% of all stocks over the past 12 months.

Where is NRC in its 52-week range?

NRC is trading at $21.64, which is 95% of its 52-week high ($22.79) and 90% above its 52-week low ($11.01).

How volatile is NRC?

NRC has a Beta of 0.49 and 52-week volatility of 57%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.